News

August 4, 2023

Podcast: Newly approved drug may slow progression of Alzheimer’s

This episode of 'Show Me the Science' focuses on approval of a drug that attacks a key protein that contributes to dementia from Alzheimer’s disease.

Podcast, Show Me the Science

March 21, 2023

Knight Alzheimer Disease Research Center is increasing equity for African Americans

The WashU center has become a national model for building relationships and boosting diversity in clinical trials.

Outlook Magazine

October 11, 2022

$9 million to fund study of ‘jumping genes’ in Alzheimer’s

Researchers from several labs to study role of transposable elements.

News Release

September 30, 2022

Risk of Alzheimer’s dementia may be predicted with help of new tool

Demographic data, imaging results, biomarkers of study participants help determine risk.

News Release

August 3, 2022

How deep sleep keeps our brains intact

WashU was first to reveal the intricate link between fragmented sleep and dementia.

Outlook Magazine

April 21, 2022

Race of people given Alzheimer’s blood tests may affect interpretation of results

3 of 4 tests performed inconsistently across racial groups.

News Release

July 8, 2021

New Alzheimer’s treatment targets identified

Study points to FDA-approved drugs that have potential to slow or reverse brain damage.

News Release

December 7, 2020

Novel form of Alzheimer’s protein found in spinal fluid indicates stage of the disease

Discovery could lead to better diagnostics, speed efforts to find treatment.

News Release

October 12, 2020

Racial differences in Alzheimer’s research focus of $15 million grant

Study investigates whether biological markers of Alzheimer’s in white patients also apply to African Americans.

News Release

October 22, 2019

Dementia patients’ adult kids diagnosed earlier than their parents

Unknown genetic factors may affect when symptoms arise.

News Release